Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Yum China YUMC Stock Distribution Signals Near Highs 20260420 Market Wrap Tech leads sector gains while consumer names lag in soft trading session Air Products and Chemicals Inc APD Ahead of Fiscal Q2 2026 Earnings Bullish Sector Catalysts Support Buy Rating Gladstone LANDO Stock Breakout Trade In Focus 20260420 How much upside is really left in CRISPR Thera CRSP Bullish Momentum 20260511 Why Radcom RDCM looks solid from every angle 094 20260508 XPO XPO notches 134 percent Q4 2025 EPS beat even as shares dip slightly in todays trading Plum PLMKU SPAC reports quiet quarter as acquisition pipeline remains focus CEO signals confidence in deal momentum Why Entergy EMP could be the turning point youve been waiting for Touches High 20260508 Valley VLYPO Q1 2026 Results Top Views on Strong Revenue RITES Q4 Results 2026 Profit Slips 23 to 130 Crore Revenue Jumps 28 Dividend of 275 Declared Grupo SIM Q1 2023 Results Fall Short EPS 207 Revenue NA National NSA Surges 123 Nearing 4360 Resistance 20260518 South SPFI Stalls at 4007 Consolidation Phase 20260520 Skillz Inc SKLZ Surges Over 15 as Trading Volume Spikes Mercury Systems MRCY Reports Strong Q1 2026 Revenue NA EPS Beats XPER Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Strategic Initiatives NanoViricides Inc NNVC Q1 2026 Earnings Narrower Loss Drives Positive Stock Reaction Schneider National Q1 2026 Earnings EPS Surpasses Expectations on Strong Cost Control EFSCP Q1 2026 Earnings EPS Misses Estimates Shares Edge Lower Gladstone Land Preferred LANDO Q1 2026 Earnings Preferred Shares Report NarrowerThanExpected Loss Amid Stable Operations ACIW Q1 2026 Earnings Earnings Beat on Strong EPS Surprise Stock Edges Lower Bionano Genomics BNGO Slips 16 as Stock Tests Key Support Near 116 Northann Corp NCL Slips 276 as Stock Tests Key Support at 015 AptarGroup ATR Edges Higher as Support Holds Testing Resistance Palvella Therapeutics PVLA Shows Resilience with Slight Gain Testing Key Resistance